Histone deacetylases modulate resistance to the therapy in lung cancer
E Contreras-Sanzón, H Prado-Garcia… - Frontiers in …, 2022 - frontiersin.org
The acetylation status of histones located in both oncogenes and tumor suppressor genes
modulate cancer hallmarks. In lung cancer, changes in the acetylation status are associated …
modulate cancer hallmarks. In lung cancer, changes in the acetylation status are associated …
Histone deacetylase inhibition in non-small cell lung cancer: hype or hope?
H Mamdani, SI Jalal - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Epigenetic modulation, including acetylation, methylation, phosphorylation, and
ubiquitination, plays a pivotal role in regulation of gene expression. Histone acetylation—a …
ubiquitination, plays a pivotal role in regulation of gene expression. Histone acetylation—a …
Histone deacetylase inhibitors as a novel targeted therapy against non-small cell lung cancer: where are we now and what should we expect?
C Damaskos, I Tomos, N Garmpis… - Anticancer …, 2018 - ar.iiarjournals.org
Non-small cell lung cancer constitutes the most common type of lung cancer, accounting for
85-90% of lung cancer, and is a leading cause of cancer-related death. Despite the progress …
85-90% of lung cancer, and is a leading cause of cancer-related death. Despite the progress …
Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?
V Petta, I Gkiozos, A Strimpakos, K Syrigos - Cancer chemotherapy and …, 2013 - Springer
Purpose Deoxyribonucleic acid is wrapped around an octamer of core histone proteins to
form a nucleosome, the basic structure of chromatin. Two main families of enzymes maintain …
form a nucleosome, the basic structure of chromatin. Two main families of enzymes maintain …
Histone deacetylase inhibitors as sanguine epitherapeutics against the deadliest lung cancer
The back-breaking resistance mechanisms generated by lung cancer cells against
epidermal growth factor receptor (EGFR), KRAS and Janus kinase 2 (JAK2) directed …
epidermal growth factor receptor (EGFR), KRAS and Janus kinase 2 (JAK2) directed …
[HTML][HTML] Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications
Genetic abnormalities have been conventionally considered as hallmarks of cancer.
However, studies over the past decades have demonstrated that epigenetic regulation also …
However, studies over the past decades have demonstrated that epigenetic regulation also …
Histone deacetylase inhibitors: emerging anticancer therapeutic agents?
Histone deacetylase inhibitors are novel anticancer agents in clinical development that
target the family of histone deacetylase (HDAC) enzymes responsible for deacetylating core …
target the family of histone deacetylase (HDAC) enzymes responsible for deacetylating core …
[HTML][HTML] The role of histone deacetylases (HDACs) in human cancer
S Ropero, M Esteller - Molecular oncology, 2007 - Elsevier
The balance of histone acetylation and deacetylation is an epigenetic layer with a critical
role in the regulation of gene expression. Histone acetylation induced by histone acetyl …
role in the regulation of gene expression. Histone acetylation induced by histone acetyl …
Understanding histone deacetylases in the cancer development and treatment: an epigenetic perspective of cancer chemotherapy
Cancer is a pathologic condition that involves genetic and epigenetic events culminating in
neoplastic transformation. Alteration in epigenetic events that regulate the transcriptional …
neoplastic transformation. Alteration in epigenetic events that regulate the transcriptional …
Characterization of histone deacetylase mechanisms in cancer development
R Hai, L He, G Shu, G Yin - Frontiers in Oncology, 2021 - frontiersin.org
Over decades of studies, accumulating evidence has suggested that epigenetic
dysregulation is a hallmark of tumours. Post-translational modifications of histones are …
dysregulation is a hallmark of tumours. Post-translational modifications of histones are …
相关搜索
- lung cancer histone deacetylases
- epigenetic perspective histone deacetylases
- molecular mechanisms histone deacetylases
- clinical implications histone deacetylases
- molecular mechanisms cancer therapy
- clinical implications cancer therapy
- cancer therapy histone deacetylases
- cancer development histone deacetylases
- human cancer histone deacetylases
- cancer chemotherapy histone deacetylases